The Journal of Thoracic and Cardiovascular Surgery | |
Japanese Oncology Group 0802: Another giant leap | |
article | |
Thomas A. D1  | |
[1] Division of Thoracic Surgery, Department of Surgery, Duke University Medical Center | |
关键词: early-stage lung cancer; segmentectomy; minimally invasive resection; | |
DOI : 10.1016/j.jtcvs.2022.09.060 | |
学科分类:心脏病和心血管学 | |
来源: Mosby, Inc. | |
【 摘 要 】
Feature Editor Note—The momentum for pulmonary segmentectomy in patients with non–small cell lung cancer was brisk even before the recent publication of the practice-changing Japanese Oncology Group (JCOG) 0802 randomized trial, which demonstrated equivalency of segmentectomy and lobectomy for overall survival in patients treated for select non–small cell lung cancer tumors. Since publication of this trial and bolstered by the recent presentation of data from the international Cancer and Leukemia Group B/Alliance 140503 trial that randomized patients to sublobar resection or lobectomy, this momentum has only accelerated.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202307020001615ZK.pdf | 202KB | download |